ANGO AngioDynamics Forecast, Technical & Fundamental Analysis
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings... Show more
ANGO is expected to report earnings to rise 28.57% to -9 cents per share on July 21
Q2'26
Est.
$-0.09
Q1'26
Beat
by $0.02
Q4'25
Beat
by $0.10
Q3'25
Beat
by $0.02
Q2'25
Beat
by $0.09
The last earnings report on April 02 showed earnings per share of -7 cents, beating the estimate of -9 cents. With 79.76K shares outstanding, the current market capitalization sits at 511.94M.
A.I. Advisor
published General Information
General Information
a manufacturer of medical devices used by radiologists, vascular surgeons and other physicians
A.I.dvisor indicates that over the last year, ANGO has been loosely correlated with STRRP. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ANGO jumps, then STRRP could also see price increases.
The Moving Average Convergence Divergence (MACD) for ANGO turned positive on June 22, 2026. Looking at past instances where ANGO's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on June 08, 2026. You may want to consider a long position or call options on ANGO as a result. In of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
ANGO moved above its 50-day moving average on June 02, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ANGO advanced for three days, in of 262 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 181 cases where ANGO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Bearish Trend Analysis
The 10-day RSI Indicator for ANGO moved out of overbought territory on May 22, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 59 cases where ANGO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ANGO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
ANGO broke above its upper Bollinger Band on May 19, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ANGO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.953) is normal, around the industry mean (4.511). P/E Ratio (0.000) is within average values for comparable stocks, (182.659). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.431). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (1.633) is also within normal values, averaging (76.815).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ANGO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 97, placing this stock worse than average.
